Delivery Order SPE2D020D0005-SPE2D325F6840

Award Date 2/24/25
Potential Completion Date 2/27/25
Potential Value $4.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Congers, NY 10920, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,724.35 firm-fixed-price contract is for the delivery of ondansetron orally disintegrating tablets (ODT) 4 mg, with a completion date of July 25, 2024. Chartwell RX LLC is a for-profit organization registered in the System for Award Management (SAM) that specializes in providing a wide range of branded and generic...
This is a $1,776.75 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of 4 mg ondansetron orally disintegrating tablets in 30-count packages. This delivery order is issued under Chartwell RX's existing Indefinite Delivery Contract (SPE2D020D0005) with DLA, which enables the company to manufacture and distribute a broad range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,973.10, is for the delivery of 4,564,795,757 units of ondansetron ODT 8 mg tablets in 30-count packages. The contract has a firm fixed price pricing type and a completion date of June 7, 2024. Chartwell RX LLC is the prime contractor and has been awarded several other federal contracts, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The delivery order is valued at $5,922.50 and has a completion date of June 7, 2024. Chartwell RX LLC is the prime contractor and does not have any noted subcontractors. This contract is not set aside for any specific...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the delivery of 8 mg ondansetron oral disintegrating tablets in 30-count packages, with a firm fixed price of $2,959.65 and a completion date of March 12, 2024. Chartwell RX is an experienced federal contractor, holding multiple indefinite delivery vehicle (IDV) contracts with the Department of Veterans...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract valued at one hundred eighteen dollars to Chartwell RX LLC of Congers, New York. The contract is for the delivery of thirty tablets of 4mg ondansetron orally disintegrating tablets, with a period of performance through September 28, 2023. No set-aside provisions were applied to this acquisition to fulfill the agency's requirements for this pharmaceutical product. As the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, with an award value of $1,973.10, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at over $7 million, which enables Chartwell RX to manufacture and distribute a broad range of medications to military treatment facilities globally. The specific product being delivered...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024. Chartwell RX LLC is the prime contractor for this award,...
This delivery order, awarded by the Defense Logistics Agency Troop Support Medical to Chartwell RX LLC, is for one hundred eighteen dollars to supply thirty ondansetron orally disintegrating tablets (ODT) 4 mg each. The place of performance is Congers, New York and all supplies are to be delivered by August 7, 2023. No set-aside provision was applied to this firm fixed price contract. The Defense Logistics Agency Troop Support Medical supports the United States military by procuring food,...
This contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of ondansetron orally disintegrating tablets in 30-count packages. The $2,369.00 firm fixed-price delivery order was issued on November 8, 2024, with a completion date of November 14, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at over $7 million with the Defense Logistics Agency (DLA) Troop Support Medical, which allows...
  • SPE2D020D0005
    Indefinite Delivery Contract
  • SPE2D020D0005-SPE2D325F6840
    Delivery Order

This is a $4,143.51 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the delivery of 30-count packages of the anti-nausea medication ondansetron orally disintegrating tablets (ODT) 8 mg. This delivery order is issued under Chartwell RX's existing $7 million single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which allows the company to manufacture and distribute a broad range of pharmaceuticals to military treatment facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on February 27, 2025.

Generated 6/1/25, 3:01 AM